LORD, ABBETT & CO. LLC

Position in JNJ — Johnson & Johnson

CIK 728100 JERSEY CITY, NJ

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$375,167,531

+$12,860,519 QoQ

Shares Held

1,477,212

-0.3% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

#126

of 4,664 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LORD, ABBETT & CO. LLC holds $1,248,570,920 across 7 Drug Manufacturers - General names. JNJ ranks #2 (30.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	427,913	$513,251,732
2	JNJ	Johnson & Johnson This page	1,477,212	$375,167,531
3	NVS	Novartis AG	1,002,335	$157,085,941
4	GILD	Gilead Sciences, Inc.	929,682	$117,456,023
5	ABBV	AbbVie Inc.	180,108	$45,322,377
6	BIIB	Biogen Inc.	130,184	$28,127,555
7	AZN	Astrazeneca PLC	64,127	$12,159,761

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$375,167,531	1,477,212	-0.3%	Shares	Sole	2026-08-14
2026-03-31	$362,307,012	1,482,192	+11.5%	Shares	Sole	2026-05-14
2025-12-31	$275,178,310	1,329,685	+16.8%	Shares	Sole	2026-02-13
2025-09-30	$211,090,657	1,138,446	+100.2%	Shares	Sole	2025-11-13
2025-06-30	$86,875,951	568,746	-19.5%	Shares	Sole	2025-08-14
2025-03-31	$117,099,458	706,099	+63.8%	Shares	Sole	2025-05-13
2024-12-31	$62,359,276	431,194	+0.0%	Shares	Sole	2025-02-14
2024-09-30	$69,858,555	431,066	+309.6%	Shares	Sole	2024-12-13
2021-03-31	$17,296,522	105,242	-86.9%	Shares	Sole	2021-05-11
2020-12-31	$126,596,157	804,398	-29.9%	Shares	Sole	2021-02-09
2020-09-30	$170,956,521	1,148,284	-20.8%	Shares	Sole	2020-11-12
2020-06-30	$203,910,828	1,449,981	+20.0%	Shares	Sole	2020-08-14
2020-03-31	$158,422,218	1,208,131	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.